title: Treatment of lichen planopilaris with mycophenolate mofetil.
abstract: Mycophenolate mofetil (MMF) is an immunosuppressive drug that has recently been used to treat autoimmune and inflammatory skin diseases. We report the first case of lichen planopilaris (LPP) successfully treated with MMF. The treatment of our patient demonstrates a novel therapeutic option for patients with LPP; MMF treatment may be preferable to azathioprine treatment because MMF has a safer adverse-effect profile. Larger studies must be performed to establish the risk-benefit ratio of various therapeutic dosages of MMF for these patients.
authors.forename: Umit
authors.initials: U
authors.lastname: Tursen
authors.forename: Hale
authors.initials: H
authors.lastname: Api
authors.forename: Tamer
authors.initials: T
authors.lastname: Kaya
authors.forename: Guliz
authors.initials: G
authors.lastname: Ikizoglu
mesh_terms: D000328:Adult; D000505:Alopecia / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008010:Lichen Planus / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D011537:Pruritus / Q000209:etiology; D012074:Remission Induction; D012536:Scalp Dermatoses / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000187:drug effects / Q000473:pathology
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid